ELLENCE

Epirubicin hydrochloride · Pharmacia & Upjohn Company LLC

Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for ELLENCE, covering 2009-12-16 to 2025-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer [Phase 2]